Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Endurance RP ( (HK:0575) ) has issued an announcement.
Deep Longevity has announced key leadership appointments as part of its strategic expansion into the U.S. market, with a commercial launch planned for early 2026. The company aims to secure over 50 enterprise clients by the end of 2026, focusing on corporate wellness, health insurers, diagnostic labs, and premium health platforms, positioning itself at the forefront of America’s preventive health revolution.
The most recent analyst rating on (HK:0575) stock is a Hold with a HK$0.79 price target. To see the full list of analyst forecasts on Endurance RP stock, see the HK:0575 Stock Forecast page.
More about Endurance RP
Deep Longevity, Inc, a subsidiary of Regent Pacific Group Limited, is a leader in explainable AI-driven aging clocks and longevity science. The company develops artificial intelligence systems that track human aging at various levels, offering software as a service solutions for consumers, physicians, and enterprises to improve health and extend lifespan.
YTD Price Performance: 217.81%
Average Trading Volume: 124,385
Technical Sentiment Signal: Hold
Current Market Cap: HK$326.8M
For a thorough assessment of 0575 stock, go to TipRanks’ Stock Analysis page.